Position in TEVA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,574,836
+$5,193 QoQ
Shares Held
151,887
+3.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Caprock Group, LLC holds $64,039,208 across 14 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,367,235 | $51,599,448 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
151,887 | $4,574,836 | |
| 3 | ZTS |
Zoetis Inc.
|
17,182 | $2,031,084 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
58,133 | $1,391,122 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
43,141 | $798,971 | |
| 6 | VTRS |
Viatris Inc
|
57,604 | $778,230 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
44,087 | $610,604 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
95,290 | $514,566 |
All Filings in TEVA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,574,836 | 151,887 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,569,643 | 146,416 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,850,139 | 141,096 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $2,234,967 | 145,411 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,169,947 | 143,827 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,619,567 | 145,370 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,149,907 | 132,302 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||